Recurrent venous thrombosis in an adequately anticoagulated patient with pemphigus vulgaris
暂无分享,去创建一个
M. Graf | F. Gentile | P. Ames
[1] S. Khezri,et al. Adjuvant rituximab in the treatment of pemphigus vulgaris: a phase II clinical trial , 2013, International journal of dermatology.
[2] S. Grando. Pemphigus autoimmunity: Hypotheses and realities , 2011, Autoimmunity.
[3] Sreeram V Ramagopalan,et al. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study , 2011, BMC medicine.
[4] D. Fanoni,et al. Coagulation activation in autoimmune bullous diseases , 2009, Clinical and experimental immunology.
[5] S. Alam,et al. Unusual thrombotic cardiac complications of Pemphigus vulgaris: a new link? , 2007, Journal of Thrombosis and Thrombolysis.
[6] D. Sheehan,et al. Deep venous thrombosis after high-dose intravenous immunoglobulin in the treatment of pemphigus vulgaris. , 2004, Cutis.
[7] E. E. Sakallıoğlu,et al. Pemphigus vulgaris and complications of systemic corticosteroid therapy: a case report. , 2003, Journal of oral science.
[8] W. O. Porter. On Pemphigus , 1819, Edinburgh medical and surgical journal.
[9] C. Cheyda,et al. Adjuvant rituximab in the treatment of pemphigus vulgaris : a phase II clinical trial , 2013 .